Supply-demand: Industry operators will increase donation campaign efforts to meet high demand
Blood and organ banks grapple with the rising medical need for organs and blood. The US Department of Health and Human Services (HHS) states that over 100,000 individuals are on the organ transplant waitlist. Kidneys account for the most organ need, followed by the liver. Despite the high call for specific organs and blood products, industry revenue hinges primarily on donations giving the blood and organ bank companies limited power meet needs or emergencies. Sadly, each year, there is a shortage of organs needed for life-saving transplants. COVID-19's mandated quarantines contracted blood donations and supply as needs continued to accelerate, hampering revenue growth compared to previous periods. Even so, industry-wide revenue has been growing at a CAGR of 2.6% to total $17.1 billion in 2023, when revenue is expected to increase 1.0%.
The Blood and Organ Banks industry includes companies that primarily collect, store and distribute human blood, blood products and human organs.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- American Red Cross
- Clinical Reference Laboratory Inc.
- ARCpoint Labs Franchise Group
- Randox Laboratories Limited
- Psychemedics Corporation
- Omega Laboratories Inc.
Methodology
LOADING...
